New York State Congenital Malformation Registry 1 List of Reportable Anomalies May 30, 2003

Total Page:16

File Type:pdf, Size:1020Kb

New York State Congenital Malformation Registry 1 List of Reportable Anomalies May 30, 2003 New York State Congenital Malformation Registry 1 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 189.0 Y Y Wilm's tumor (nephroblastoma) only is reportable 190.5 N Y Retinoblastoma 191.0 N Y Central nervous system neoplasm, cerebrum 191.1 N Y Central nervous system neoplasm, frontal lobe 191.2 N Y Central nervous system neoplasm, temporal lobe 191.3 N Y Central nervous system neoplasm, parietal lobe 191.4 N Y Central nervous system neoplasm, occipital lobe 191.5 N Y Central nervous system neoplasm, ventricles 191.6 N Y Central nervous system neoplasm, cerebellum nos 191.7 N Y Central nervous system neoplasm, brain stem 191.8 Y Y Central nervous system neoplasm, other parts of the brain (specify area) 191.9 Y Y Central nervous system neoplasm, brain unspecified (try not to use) 194.0 Y Y Neuroblastoma only is reportable 208.9 N Y Leukemia, congenital 228.00 Y Y Hemangioma - skin > 4" diameter N (m) Hemangioma, of unspecified site N (m) Noncavernous, single, small hemangioma (less than 4" diameter) 228.02 Y Y Hemangioma, intracranial structures (specify region if possible) 228.03 N Y Hemangioma, retina 228.04 Y Y Hemangioma, intra abdominal structures (specify structure) 228.09 Y Y Hemangioma, of other sites (specify site) 228.1 Y Y Lymphangioma, any site (specify site) 237.70 N Y Neurofibromatosis, unspecified 237.71 N Y Neurofibromatosis type I Y Von Recklinghausen's disease 237.72 N Y Acoustic neurofibromatosis Y Neurofibromatosis type II 238.8 Y Y Teratoma, abdomen New York State Congenital Malformation Registry 2 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 238.8 Y Y Teratoma, head and face Y Teratoma, neck Y Teratoma, other specified sites (please specify site) Y Teratoma, sacral, coccyxgeal 238.9 Y Y Teratoma, nos 243. N Y Hypothyroidism, congenital 246.1 N Y Congenital dyshormonogenic goiter 250.30 N Y Diabetes with other coma adult onset type or unspecified Y Diabetes with other coma, type II 250.31 N Y Diabetes with other coma juvenile type Y Diabetes with other coma, type I 250.90 N Y Diabetes with unspecified complication adult onset type Y Diabetes with unspecified complication, type II Y Diabetes with unspecified complication, unspecified type 250.91 N Y Diabetes with unspecified complication, juvenile type Y Diabetes with unspecified complication, type I 253.0 N Y Acromegaly and gigantism 253.1 Y Y Other and unspecified anterior pituitary hyperfunction 253.2 N Y Panhypopituitarism, congenital 253.3 N Y Pituitary dwarfism 253.4 Y Y Other anterior pituitary disorders 253.5 N Y Diabetes insipidus 253.8 Y Y Other disorder of the pituitary & syndromes - diencephalohypophyseal origin 255.2 Y Y Adrenogenital disorders 257.8 N Y Testicular feminization 259.4 Y Y Dwarfism, not elsewhere classified 259.8 Y Y Other specified endocrine disorders Y Progeria 270.0 Y Y Disturbances of amino acid transport 270.1 N Y Phenylketonuria (PKU) New York State Congenital Malformation Registry 3 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 270.2 Y Y Albinism Y Other disturbances of aromatic amino-acid metabolism 270.3 Y Y Disturbances of branched-chain amino-acid metabolism 270.4 Y Y Disturbances of sulphur-bearing amino-acid metabolism 270.5 Y Y Disturbances of histadine metabolism 270.6 Y Y Disorders of urea cycle metabolism 270.7 Y Y Hyperglycinemia Y Other disturbances straight-chain amino-acid metabolism 270.8 Y Y 0ther specified disorders of amino-acid metabolism 271.0 Y Y Glycogenosis 271.1 N Y Galactosemia 271.8 Y Y Other specified disorders of carbohydrate transport 272.7 Y Y Lipidoses 273.0 Y Y Polyclonal hypergammaglobulenemia 273.1 Y Y Monoclonal paraproteinemia 273.2 Y Y Other paraproteinemias 273.3 Y Y Macroglobulinemia 273.8 Y Y Other disorders of plasma protein metabolism 275.0 Y Y Disorders of iron metabolism 275.1 Y Y Disorders of copper metabolism 275.3 Y Y Disorders of phosphorus metabolism (do not report if <1500g) Y Hypophosphatemic rickets 275.49 Y ONLY REPORT HYPOCALCEMIA IF ANOTHER METABOLIC ANOMALY IS PRESENT Y Disorders of calcium metabolism 275.8 Y Y Other specified disorders of mineral metabolism 275.9 Y Y Unspecified disorders of mineral metabolism 277.00 N Y Cystic fibrosis without mention of meconium ileus 277.01 N Y Cystic fibrosis with mention of meconium ileus New York State Congenital Malformation Registry 4 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 277.1 Y Y Disorders of porphyrin metabolism 277.2 Y Y Other disorders of purine and pyrimidine metabolism 277.3 Y Y Amyloidosis 277.4 Y DO NOT REPORT TRANSIENT NEONATAL HYPERBILIRUBINEMIA Y Crigler-Najar (Gilberts) syndrome Y Disorders of bilirubin excretion 277.5 Y Y Hurler's syndrome Y Lipochondrodystrophy Y Mucopolysaccharidosis 277.6 Y Y Alpha 1-antitrypsin deficiency Y Other deficiencies of circulatory enzymes 277.8 Y Y Other specified disorders of metabolism 279.01 N Y Selective IGA immunodeficiency 279.02 N Y Selective IGM immunodeficiency 279.03 N Y Other selective immunoglobulin deficiencies 279.04 N Y Congenital Hypogammaglobulinemia Y Congenital hypogammaglobulinemia 279.05 N Y Immunodeficiency with increased IGM Y Immunodeficiency with increased IgM 279.06 N Y Common variable immunodeficiency 279.09 Y Y Other immune deficiency 279.11 N Y DiGeorge's syndrome 279.12 N Y Wiskott-Aldrich syndrome 279.13 N Y Nezelof syndrome 279.19 Y Y Other deficiency of cell mediated immunity 279.2 Y Y Combined Immunty Deficiency 282.0 N Y Hereditary spherocytosis 282.1 N Y Hereditary elliptocytosis 282.2 Y Y Anemias due to disorders of glutathione metabolism Y Glucose-6-phosphate dehydrogenase [G-6-PD] deficiency New York State Congenital Malformation Registry 5 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 282.4 Y Y Thalassemias 282.60 N Y Sickle-cell anemia, unspecified 282.61 N Y Hb-S disease without mention of crisis 282.62 N Y Hb-S disease with crisis 282.63 N Y Sickle cell / Hb-c disease 282.69 Y Y Other sickle-cell anemia 282.7 Y Y Other hemoglobinopathies 282.8 Y Y Other specified hereditary anemias 284.0 Y Y Constitutional aplastic anemia Y Red cell aplasia 286.0 N Y Congenital factor VIII disorder Y Hemophilia 286.1 N Y Congenital factor IX disorder 286.2 N Y Congenital factor XI deficiencies 286.3 Y Y Congenital deficiency of other clotting factors 286.4 N Y Von Willebrand's disease 287.3 Y REPORT ONLY IF CONGENITAL OR HEREDITARY Y Kasabach-Merritt syndrome Y Primary thromboctyopenia 288.2 Y Y Genetic anomalies of leukocytes Y Pelger-Huet syndrome 289.7 Y Y Methemoglobinemia if congenital or hereditary 330.0 Y Y Leukodystrophy 330.1 Y Y Cerebral lipidoses Y Gangliosidosis Y Tay-Sachs disease 330.8 Y Y Cerebral Dengeration of childhood - specify 333.2 N Y Isaac-Mertens syndrome Y Myoclonus 333.91 N Y Hallervorden-Spatz (stiffman) syndrome New York State Congenital Malformation Registry 6 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 334.1 N Y Hereditary spastic paraplegia 334.2 Y Y Primary cerebellar degeneration 335.0 N Y Werdnig-Hoffman disease 335.11 N Y Kugelberg-Welander disease 343.0 N Y Diplegic cerebral palsy 343.1 N Y Hemiplegic cerebral palsy 343.2 N Y Quadriplegic cerebral palsy 343.9 N Y Infantile cerebral palsy, unspecified 345.6 Y Y Infantile spasms - congenital 352.6 N Y Moebius syndrome Y Multiple cranial nerve palsies 356.0 Y Y Hereditary peripheral neuropathy 356.1 Y Y Peroneal muscular atrophy 356.2 Y Y Hereditary sensory neuropathy 356.3 N Y Refsum's disease 359.0 Y Y Congenital hereditary muscular dystrophy 359.1 Y Y Hereditary progressive muscular dystrophy - specify 359.2 Y Y Myotonic disorders 359.8 Y Y Leigh syndrome Y Myopathy, congenital 378.71 N Y Duane-Stilling-Turk syndrome 425.3 N Y Endocardial fibroelastosis 426.7 Y Y Wolff-Parkinson-White syndrome 524.00 N Y Unspecified anomaly of jaw size 524.01 N Y Macrognathia Y Maxillary hyperplasia Y Prominent maxilla 524.02 N Y Mandibular hyperplasia New York State Congenital Malformation Registry 7 List of Reportable Anomalies May 30, 2003 ICD Narrative Rpta Code Required ble Notes & Description __________________________________________________________________________________________________________ 524.03 N Y Maxillary hypoplasia Y Micrognathia 524.04 N Y Mandibular hypoplasia 524.05 N Y Macrogenia 524.06 N Y Microgenia 524.09 Y Y Other specified anomalies of jaw (specify) 550.00 N PLEASE REPORT FEMALES ONLY Y Inguinal hernia with gangrene, left only Y Inguinal hernia with gangrene, right only Y Inguinal hernia with gangrene, unilateral unspecified Y Inguinal hernia with gangrene, unspecified 550.02 N PLEASE REPORT FEMALES ONLY Y Inguinal hernia with gangrene, bilateral 550.10 N PLEASE REPORT FEMALES ONLY Y Inguinal hernia with
Recommended publications
  • Educational Paper Ciliopathies
    Eur J Pediatr (2012) 171:1285–1300 DOI 10.1007/s00431-011-1553-z REVIEW Educational paper Ciliopathies Carsten Bergmann Received: 11 June 2011 /Accepted: 3 August 2011 /Published online: 7 September 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Cilia are antenna-like organelles found on the (NPHP) . Ivemark syndrome . Meckel syndrome (MKS) . surface of most cells. They transduce molecular signals Joubert syndrome (JBTS) . Bardet–Biedl syndrome (BBS) . and facilitate interactions between cells and their Alstrom syndrome . Short-rib polydactyly syndromes . environment. Ciliary dysfunction has been shown to Jeune syndrome (ATD) . Ellis-van Crefeld syndrome (EVC) . underlie a broad range of overlapping, clinically and Sensenbrenner syndrome . Primary ciliary dyskinesia genetically heterogeneous phenotypes, collectively (Kartagener syndrome) . von Hippel-Lindau (VHL) . termed ciliopathies. Literally, all organs can be affected. Tuberous sclerosis (TSC) . Oligogenic inheritance . Modifier. Frequent cilia-related manifestations are (poly)cystic Mutational load kidney disease, retinal degeneration, situs inversus, cardiac defects, polydactyly, other skeletal abnormalities, and defects of the central and peripheral nervous Introduction system, occurring either isolated or as part of syn- dromes. Characterization of ciliopathies and the decisive Defective cellular organelles such as mitochondria, perox- role of primary cilia in signal transduction and cell isomes, and lysosomes are well-known
    [Show full text]
  • Mimics, Miscalls, and Misses in Pancreatic Disease Koenraad J
    Mimics, Miscalls, and Misses in Pancreatic Disease Koenraad J. Mortelé1 The radiologist plays a pivotal role in the detection and This chapter will summarize, review, and illustrate the characterization of pancreatic disorders. Unfortunately, the most common and important mimics, miscalls, and misses in accuracy of rendered diagnoses is not infrequently plagued by pancreatic imaging and thereby improve diagnostic accuracy a combination of “overcalls” of normal pancreatic anomalies of diagnoses rendered when interpreting radiologic studies of and variants; “miscalls” of specific and sometimes pathog- the pancreas. nomonic pancreatic entities; and “misses” of subtle, uncom- mon, or inadequately imaged pancreatic abnormalities. Ba- Normal Pancreatic Anatomy sic understanding of the normal and variant anatomy of the The Gland pancreas, knowledge of state-of-the-art pancreatic imaging The coarsely lobulated pancreas, typically measuring ap- techniques, and familiarity with the most commonly made mis- proximately 15–20 cm in length, is located in the retroperito- diagnoses and misses in pancreatic imaging is mandatory to neal anterior pararenal space and can be divided in four parts: avoid this group of errors. head and uncinate process, neck, body, and tail [4]. The head, neck, and body are retroperitoneal in location whereas the Mimics of pancreatic disease, caused by developmental tail extends into the peritoneal space. The pancreatic head is variants and anomalies, are commonly encountered on imag- defined as being to the right of the superior mesenteric vein ing studies [1–3]. To differentiate these benign “nontouch” en- (SMV). The uncinate process is the prolongation of the medi- tities from true pancreatic conditions, radiologists should be al and caudal parts of the head; it has a triangular shape with a familiar with them, the imaging techniques available to study straight or concave anteromedial border.
    [Show full text]
  • Treatment of Congenital Ptosis
    13 Review Article Page 1 of 13 Treatment of congenital ptosis Vladimir Kratky1,2^ 1Department of Ophthalmology, Queen’s University, Kingston, Canada; 21st Medical Faculty, Charles University, Prague, Czech Republic Correspondence to: Vladimir Kratky, BSc, MD, FRCSC, DABO. Associate Professor of Ophthalmology, Director of Ophthalmic Plastic and Orbital Surgery, Oculoplastics Fellowship Director, Queen’s University, Kingston, Canada; 1st Medical Faculty, Charles University, Prague, Czech Republic. Email: [email protected]. Abstract: Congenital ptosis is an abnormally low position of the upper eyelid, with respect to the visual axis in the primary gaze. It can be present at birth or manifest itself during the first year of life and can be bilateral or unilateral. Additionally, it may be an isolated finding or part of a constellation of signs of a specific syndrome or systemic associations. Depending on how much it interferes with the visual axis, it may be considered as a functional or a cosmetic condition. In childhood, functional ptosis can lead to deprivation amblyopia and astigmatism and needs to be treated. However, even mild ptosis with normal vision can lead to psychosocial problems and correction is also advised, albeit on a less urgent basis. Although, patching and glasses can be prescribed to treat the amblyopia, the mainstay of management is surgical. There are several types of surgical procedure available depending on the severity and etiology of the droopy eyelid. The first part of this paper will review the different categories of congenital ptosis, including more common associated syndromes. The latter part will briefly cover the different surgical approaches, with emphasis on how to choose the correct condition.
    [Show full text]
  • Research Day 2021 Program
    Western Michigan University ScholarWorks at WMU Research Day WMU Homer Stryker M.D. School of Medicine 2021 Research Day 2021 Program Western Michigan University Homer Stryker M.D. School of Medicine Follow this and additional works at: https://scholarworks.wmich.edu/medicine_research_day Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons WMU ScholarWorks Citation Homer Stryker M.D. School of Medicine, Western Michigan University, "Research Day 2021 Program" (2021). Research Day. 298. https://scholarworks.wmich.edu/medicine_research_day/298 This Abstract is brought to you for free and open access by the WMU Homer Stryker M.D. School of Medicine at ScholarWorks at WMU. It has been accepted for inclusion in Research Day by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. th 38 Annual Kalamazoo Community Medical and Health Sciences Virtual Research Day Wednesday, April 21, 2021 8:00 a.m. – 12:00 p.m. TABLE OF CONTENTS INTRODUCTION ........................................................................................................... 4 KEYNOTE SPEAKER.................................................................................................... 6 SCHEDULE ..................................................................................................................... 7 ORAL PRESENTATIONS ............................................................................................. 8 ORAL ABSTRACTS ....................................................................................................
    [Show full text]
  • Novel Anterior Segment Phenotypes Resulting from Forkhead Gene Alterations: Evidence for Cross-Species Conservation of Function
    Novel Anterior Segment Phenotypes Resulting from Forkhead Gene Alterations: Evidence for Cross-Species Conservation of Function Ordan J. Lehmann,1 Stephen Tuft,2 Glen Brice,3 Richard Smith,4 Åsa Blixt,5 Rachel Bell,3 Bengt Johansson,6 Tim Jordan,1 Roger A. Hitchings,2 Peng T. Khaw,2 Simon W. M. John,4 Peter Carlsson,5 and Shomi S. Bhattacharya1 PURPOSE. Mutations in murine and human versions of an ances- cause it may affect the clinical management of certain trally related gene usually result in similar phenotypes. How- glaucoma subtypes and lead to excessive treatment. The ever, interspecies differences exist, and in the case of two FOXC1 and Foxe3 data, taken together with the novel ocular forkhead transcription factor genes (FOXC1 and FOXC2), phenotypes of FOXC2 mutations, highlight the remarkable these differences include corneal or anterior segment pheno- cross-species conservation of function among forkhead genes. types, respectively. This study was undertaken to determine (Invest Ophthalmol Vis Sci. 2003;44:2627–2633) DOI:10.1167/ whether such discrepancies provide an opportunity for iden- iovs.02-0609 tifying novel human–murine ocular phenotypes. METHODS. Four pedigrees with early-onset glaucoma pheno- types secondary to segmental chromosomal duplications or ecognition that mutations in orthologous genes frequently deletions encompassing FOXC1 and 18 individuals from 9 Rcause similar phenotypes has allowed the field of compar- FOXC2 mutation pedigrees underwent detailed ocular pheno- ative genetics to contribute to the understanding of human typing. Subsequently, mice with mutations in Foxc1 or a re- disease. As the human, murine, and Drosophila PAX6 mutants lated forkhead gene, Foxe3, were assessed for features of the (aniridia, Small eye, and eyeless) demonstrate, genotypic con- human phenotypes.
    [Show full text]
  • Koolen-De Vries Syndrome: Clinical Report of an Adult and Literature Review
    Case Report Cytogenet Genome Res 2016;150:40–45 Accepted: July 25, 2016 DOI: 10.1159/000452724 by M. Schmid Published online: November 17, 2016 Koolen-de Vries Syndrome: Clinical Report of an Adult and Literature Review Claudia Ciaccio Chiara Dordoni Marco Ritelli Marina Colombi Division of Biology and Genetics, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia , Italy Key Words Koolen-de Vries syndrome (KdS, also known as 17q21.31 · Deletion · Joint hypermobility · KANSL1 17q21.31 microdeletion syndrome, OMIM #610443) is a rare genetic disorder (prevalence 1/16,000) characterized by typical facial dysmorphisms, cardiac and renal defects, Abstract developmental delay, and intellectual disability of vari- Koolen-de Vries syndrome (KdS) is a rare genetic condition able level [Tan et al., 2009]. The disorder was initially de- characterized by typical facial dysmorphisms, cardiac and re- scribed as a form of mental retardation caused by a 440– nal defects, skeletal anomalies, developmental delay, and in- 680-kb deletion in the 17q21.31 region, typically encom- tellectual disability of variable level. It is caused by a 440– passing 5 genes: CRHR1 (OMIM 122561), MAPT 680-kb deletion in the 17q21.31 region, encompassing (OMIM 157140), IMP5 (OMIM 608284), STH (OMIM CRHR1 , MAPT , IMP5 , STH , and KANSL1 , or by an intragenic 607067), and KANSL1 (OMIM 612452)* [Koolen et al., KANSL1 mutation. The majority of the patients reported are 2006]. Recently,* it has been shown* that haploinsufficien- pediatric or young adults, and long-term studies able to de- cy* of KANSL1 by itself, due to single* nucleotide variants fine the prognosis of the disease are lacking.
    [Show full text]
  • Phenotypic and Genotypic Characterisation of Noonan-Like
    1of5 ELECTRONIC LETTER J Med Genet: first published as 10.1136/jmg.2004.024091 on 2 February 2005. Downloaded from Phenotypic and genotypic characterisation of Noonan-like/ multiple giant cell lesion syndrome J S Lee, M Tartaglia, B D Gelb, K Fridrich, S Sachs, C A Stratakis, M Muenke, P G Robey, M T Collins, A Slavotinek ............................................................................................................................... J Med Genet 2005;42:e11 (http://www.jmedgenet.com/cgi/content/full/42/2/e11). doi: 10.1136/jmg.2004.024091 oonan-like/multiple giant cell lesion syndrome (NL/ MGCLS; OMIM 163955) is a rare condition1–3 with Key points Nphenotypic overlap with Noonan’s syndrome (OMIM 163950) and cherubism (OMIM 118400) (table 1). N Noonan-like/multiple giant cell lesion syndrome (NL/ Recently, missense mutations in the PTPN11 gene on MGCLS) has clinical similarities with Noonan’s syn- chromosome 12q24.1 have been identified as the cause of drome and cherubism. It is unclear whether it is a Noonan’s syndrome in 45% of familial and sporadic cases,45 distinct entity or a variant of Noonan’s syndrome or indicating genetic heterogeneity within the syndrome. In the cherubism. 5 study by Tartaglia et al, there was a family in which three N Three unrelated patients with NL/MGCLS were char- members had features of Noonan’s syndrome; two of these acterised, two of whom were found to have mutations had incidental mandibular giant cell lesions.3 All three in the PTPN11 gene, the mutation found in 45% of members were found to have a PTPN11 mutation known to patients with Noonan’s syndrome.
    [Show full text]
  • Complications of Splenectomy 2020; 4(2): 218-222 Received: 08-02-2020 Dr
    International Journal of Surgery Science 2020; 4(2): 218-222 E-ISSN: 2616-3470 P-ISSN: 2616-3462 © Surgery Science Complications of splenectomy www.surgeryscience.com 2020; 4(2): 218-222 Received: 08-02-2020 Dr. Ketan Vagholkar Accepted: 10-03-2020 Dr. Ketan Vagholkar DOI: https://doi.org/10.33545/surgery.2020.v4.i2d.420 Professor, Department of Surgery. DY Patil University School of Abstract Medicine Navi Mumbai, Spleen is an important organ of the reticuloendothelial system. It plays a crucial role in the immunological Maharashtra, India system of the body. Understanding the consequences and diagnosis of hyposlenic and asplenic states is essential. Splenectomy is performed for a variety of indications ranging from haematological conditions to trauma. Complications of splenectomy include surgical as well as immunological. Overwhelming post splenectomy infection is one of the most dreaded complication with high mortality. The physiological basis of immunological function of the spleen, hyposplenism and complications of splenectomy are presented in this paper. Keywords: Post splenectomy, complications, hyposplenia, OPSI Introduction Spleen is a very important constituent organ of the reticuloendothelial system. The organ is crucial in regulating immune homeostasis through its ability to link innate and adoptive immunity in the process of protecting against infection. Hyposplenism is impairment of splenic function. It is usually acquired and caused by severe haematological and immunological disorders. Asplenia refers to the absence of the spleen which is rarely congenital but predominantly post-surgical (splenectomy). The most important complication of asplenic state is infectious complications [1]. These infections have high mortality. In addition to infectious complications, splenectomy can lead to a series of other complications.
    [Show full text]
  • Imaging Pearls of the Annular Pancreas on Antenatal Scan and Its
    Imaging pearls of the annular pancreas on antenatal scan and its diagnostic Case Report dilemma: A case report © 2020, Roul et al Pradeep Kumar Roul,1 Ashish Kaushik,1 Manish Kumar Gupta,2 Poonam Sherwani,1 * Submitted: 22-08-2020 Accepted: 10-09-2020 1 Department of Radiodiagnosis, All India Institute of Medical Sciences, Rishikesh 2 Department of Pediatric Surgery, All India Institute of Medical Sciences, Rishikesh License: This work is licensed under a Creative Commons Attribution 4.0 Correspondence*: Dr. Poonam Sherwani. DNB, EDIR, Fellow Pediatric Radiology, Department of International License. Radiodiagnosis, All India Institute of Medical Sciences, Rishikesh, E-mail: [email protected] DOI: https://doi.org/10.47338/jns.v9.669 KEYWORDS ABSTRACT Annular pancreas, Background: Annular pancreas is an uncommon cause of duodenal obstruction and rarely Duodenal obstruction, causes complete duodenal obstruction. Due to its rarity of identification in the antenatal Double bubble sign, period and overlapping imaging features with other causes of duodenal obstruction; it is Hyperechogenic band often misdiagnosed. Case presentation: A 33-year-old primigravida came for routine antenatal ultrasonography at 28 weeks and 4 days of gestational age. On antenatal ultrasonography, dilated duodenum and stomach were seen giving a double bubble sign and a hyperechoic band surrounding the duodenum. Associated polyhydramnios was also present. Fetal MRI was also done. Postpartum ultrasonography demonstrated pancreatic tissue surrounding the duodenum. The upper gastrointestinal contrast study showed a non-passage of contrast beyond the second part of the duodenum. Due to symptoms of obstruction, the neonate was operated on, and the underlying cause was found to be the annular pancreas.
    [Show full text]
  • Loss of Correction in Cubitus Varus Deformity After Osteotomy
    Loss of correction in cubitus varus deformity after osteotomy Chao You Shenzhen children's hospital Yibiao Zhou Shenzhen children's hospital https://orcid.org/0000-0001-9754-1089 Jingming Han ( [email protected] ) Research article Keywords: cubitus varus osteotomy Loss of correction Posted Date: May 5th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-26279/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/14 Abstract Purpose Cubitus varus deformity in the pediatric population is an infrequent but clinically important disease to orthopedic surgeons. Since these patient populations are different in many respects, we sought out to investigate the rates of loss of correction over time as well as the factors associated with loss of correction in pediatric patients undergoing osteotomy for treatment of cubitus varus deformity. Methods Between 2008-7 and 2017-7, we treated 30 cases of cubital varus had underwent the the osteotomy. We compared preoperative and postoperative clinical and imaging parameters (H-cobb angle,Baumman angle) for all patients. Postoperative evaluation was performed by telephone interview. Results In our study,there were 30 patients,included 17 males and 13 females.the mean age was 75 months old.In the rst follow-up,Approximately 80 % of patients had a loss of correction of H-cobband 83% of patients at the second follow-up. The Baumann angle also had a loss of correction,about 57% was lost at the rst follow-up,and 43% was lost at the second follow-up. The average interval between the rst follow-up and the second follow-up was 24 days The H-cobb angle mean loss was 2.4°.There was a statistically signicant difference between the H-cobb angle measured before surgery and the angle measured after surgery (p <0.05).
    [Show full text]
  • And Pancreas Divisum
    Gut: first published as 10.1136/gut.27.2.203 on 1 February 1986. Downloaded from Gut 1986, 27, 203-212 Progress report A historical perspective on the discovery of the accessory duct of the pancreas, the ampulla 'of Vater' andpancreas divisum SUMMARY The discovery of the accessory duct of the pancreas is usually ascribed to Giovanni Domenico Santorini (1681-1737), after whom this structure is named. The papilla duodeni (ampulla 'of Vater', or papilla 'of Santorini') is named after Abraham Vater (1684-1751) or after GD Santorini. Pancreas divisum, a persistence through non-fusion of the embryonic dorsal and ventral pancreas is a relatively common clinical condition, the discovery of which is usually ascribed to Joseph Hyrtl (1810-1894). In this review I report that pancreas divisum, the accessory duct and the papilla duodeni (ampulla 'of Vater') had all been observed and the observations published during the 17th century by at least seven anatomists before Santorini, Vater, and Hyrtl. I further suggest, in the light of frequent anatomical misattributions in common usage, that anatomical structures be referred to only by their proper anatomical names. The human pancreas forms during the seventh week of embryonic http://gut.bmj.com/ development by the fusion of two pancreatic primordia, one dorsal and the other ventral.1 4Each of these two primordia contains a duct, opening into the duodenum. After fusion, the distal part of the main duct of the pancreas ('Wirsung's duct') is formed from the duct of the ventral pancreas, and its proximal part from the proximal portion of the duct of the dorsal primordium.
    [Show full text]
  • Genetics of Congenital Hand Anomalies
    G. C. Schwabe1 S. Mundlos2 Genetics of Congenital Hand Anomalies Die Genetik angeborener Handfehlbildungen Original Article Abstract Zusammenfassung Congenital limb malformations exhibit a wide spectrum of phe- Angeborene Handfehlbildungen sind durch ein breites Spektrum notypic manifestations and may occur as an isolated malforma- an phänotypischen Manifestationen gekennzeichnet. Sie treten tion and as part of a syndrome. They are individually rare, but als isolierte Malformation oder als Teil verschiedener Syndrome due to their overall frequency and severity they are of clinical auf. Die einzelnen Formen kongenitaler Handfehlbildungen sind relevance. In recent years, increasing knowledge of the molecu- selten, besitzen aber aufgrund ihrer Häufigkeit insgesamt und lar basis of embryonic development has significantly enhanced der hohen Belastung für Betroffene erhebliche klinische Rele- our understanding of congenital limb malformations. In addi- vanz. Die fortschreitende Erkenntnis über die molekularen Me- tion, genetic studies have revealed the molecular basis of an in- chanismen der Embryonalentwicklung haben in den letzten Jah- creasing number of conditions with primary or secondary limb ren wesentlich dazu beigetragen, die genetischen Ursachen kon- involvement. The molecular findings have led to a regrouping of genitaler Malformationen besser zu verstehen. Der hohe Grad an malformations in genetic terms. However, the establishment of phänotypischer Variabilität kongenitaler Handfehlbildungen er- precise genotype-phenotype correlations for limb malforma- schwert jedoch eine Etablierung präziser Genotyp-Phänotyp- tions is difficult due to the high degree of phenotypic variability. Korrelationen. In diesem Übersichtsartikel präsentieren wir das We present an overview of congenital limb malformations based Spektrum kongenitaler Malformationen, basierend auf einer ent- 85 on an anatomic and genetic concept reflecting recent molecular wicklungsbiologischen, anatomischen und genetischen Klassifi- and developmental insights.
    [Show full text]